Combined Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) and Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Therapy to Restore Fertility in Patients With Obesity, Polycystic Ovary Syndrome, and
6 hours ago
- #PCOS
- #obesity
- #fertility
- Combined GLP-1RA and SGLT2i therapy was used to restore fertility in obese women with PCOS and newly diagnosed type 2 diabetes.
- Two case studies showed significant weight loss (23% and 10.2%) leading to menstrual normalization and spontaneous conception within seven months.
- Medications were discontinued upon pregnancy confirmation, resulting in uncomplicated pregnancies and healthy live births.
- Early combination therapy may expedite spontaneous conception in high-risk populations, though safety profiles for embryotoxicity require further study.
- Current clinical standards recommend transitioning to metformin and/or insulin before planning pregnancy until more safety data is available.